⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
globenewswire.com
ATYR
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ATYR
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
globenewswire.com
ATYR
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
globenewswire.com
ATYR
Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders
prnewswire.com
ATYR
Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders
globenewswire.com
ATYR
ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
prnewswire.com
ATYR
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class Action – Contact The Gross Law Firm to Learn More
globenewswire.com
ATYR
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
businesswire.com
ATYR
ATYR DEADLINE ALERT: Hagens Berman Alerts aTyr Pharma (ATYR) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action
globenewswire.com
ATYR